Morgan Stanley’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89K | Hold |
|
|||||
|
2025
Q1 | $1.62K | Hold |
|
|||||
|
2024
Q4 | $2.09K | Hold |
|
|||||
|
2024
Q3 | $1.68K | Hold |
|
|||||
|
2024
Q2 | $1.49K | Hold |
|
|||||
|
2024
Q1 | $2.08K | Sell |
|
|||||
|
2023
Q4 | $4.68K | Buy |
|
|||||
|
2023
Q3 | $2.82K | Hold |
|
|||||
|
2023
Q2 | $3.39K | Buy |
|
|||||
|
2023
Q1 | $5.22K | Buy |
|
|||||
|
2022
Q4 | $2.16K | Sell |
|
|||||
|
2022
Q3 | $3K | Sell |
|
|||||
|
2022
Q2 | $3K | Sell |
|
|||||
|
2022
Q1 | $43K | Sell |
|
|||||
|
2021
Q4 | $125K | Sell |
|
|||||
|
2021
Q3 | $229K | Buy |
|
|||||
|
2021
Q2 | $274K | Buy |
|
|||||
|
2021
Q1 | $105K | Sell |
|
|||||
|
2020
Q4 | $1.26M | Buy |
|
|||||
|
2020
Q3 | $379K | Buy |
|
|||||
|
2020
Q2 | $48K | Buy |
|
|||||
|
2020
Q1 | $7K | Sell |
|
|||||
|
2019
Q4 | $89K | Buy |
|
|||||
|
2019
Q3 | $121K | Buy |
|
|||||
|
2019
Q2 | $25K | Buy |
|